Ocugen Files Request with US FDA to Start Covaxin Trials in US
The company ‘Ocugen’, US partner of Bharat BioTech for the Covaxin novel corona virus vaccine said, it has submitted the application of the Investigational New Drug (IND) to the US FDA for the purpose of conducting the clinical trials, and this development comes a day after the World Health Organisation (WHO) will sought more details […]
Continue Reading